ArticleHuman reproduction (Oxford, England)2022

A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol.

Manuel Fernández Sánchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.